OneCare LLC and Glooko, Inc. Announces Collaborative Solution for Advanced Diabetes Management

ACCESSWIRE

Sat, Oct 11, 2014, 5:00 AM

Innovative Wireless Platform Monitors Patient Compliance

ATLANTA, GA / ACCESSWIRE / November 11, 2014 / OneCare LLC, an innovative healthcare IT company headquartered at the Advanced Technology Development Center at Georgia Tech, announced today a collaborative solution with Glooko, Inc. for the management of diabetes.

Privately-held Atlanta, GA-based OneCare LLC has developed an easy to use, open, care engagement platform that manages patients with chronic illnesses. OneCare's open platform can connect, through Bluetooth, RFID, Wi-FI and other wired and wireless communication technologies with most of the "connected" self-test medical devices on the market. The web and mobile platform enables nurses and doctors to actively manage a patient population for health systems, health plans, accountable care organizations, retail pharmacies, pharmacy benefits managers and employer groups. The OneCare platform is open and device-agnostic and can transmit and receive real time updates to integrated insurers, third party administrators and health system electronic medical records.

Glooko, a leading mobile diabetes management company, recently launched its 'Glooko MeterSync Blue' device that allows over 30 existing glucometers to wirelessly sync directly with popular IOS and Android devices opening up a much more self-connected system for affected individuals to interact with their glucose data. With more than 8.3% of the United States population diagnosed with diabetes, the chronic condition is now considered a growing pandemic.

OneCare is proud to announce the integration of Glooko with its next generation connected healthcare platform enabling connectivity with the tens of millions of glucometers already in use and insured worldwide. The OneCare system is at the forefront of the patient engagement and social connectivity market, giving individuals and their families much simpler yet more powerful ways to manage chronic conditions. The new connection with Glooko leverages the OneCare platform to effectively manage wellness, glucose data trends and insulin therapies in addition to the added services of real-time alerts for abnormal readings, personalized goal setting, and family and care team connectivity.

Since 1980, the number of diagnosed diabetics in the US has increased from 7 Million to 28 Million in 2013 and is expected to grow to over 45 million diabetics by 2035. According to a study presented by Gurkirpal Singh, MD, of Stanford University at the 2013 American Diabetes Association Scientific Sessions, hypoglycemia was the cause of approximately 270,000 hospitalizations annually at a cost to the U.S. healthcare system of more than $13 billion in 2009.

Gary Austin, CEO of OneCare, said, "The integration of the OneCare Platform with Glooko's seamless glucose monitoring results in an unsurpassed level of quality service, value, convenience, and outcomes improvement. Finding a workable solution to managing and encouraging patient compliance in the administration of pharmaceuticals and health monitoring has become an elusive goal of many healthcare organizations. Together, we expect to be able to reduce avoidable episodes of care, which currently account for 60 percent of billed medical expenses."

Holly McGarraugh, VP of Strategic Alliances at Glooko, added, "We are excited to partner with OneCare's platform to connect patients and their diabetes data with their entire care team. Together we can help healthcare organizations and their patients with diabetes improve outcomes through better coordination, allowing healthcare professionals to focus on the right patients at the right time."

Austin continued, "We have received positive feedback from employers that provide healthcare for their employees and those seeking proactive ways to alter their insureds' behavior to maximize their premium dollar. We look forward to expanding our footprint through retirement communities, care giver networks, and private insurers."

About Glooko, Inc.:

Glooko is an innovative Silicon Valley company that delivers a FDA-cleared, HIPAA-complaint SaaS and mobile platform designed to improve health outcomes for people with diabetes and reduce the costs associated with diabetes population management. Glooko's analytics and care management platform includes direct integration to all major glucose meters and other health devices to supply timely, verified patient data such as blood glucose, carbs, insulin, activity, blood pressure, and weight data. Glooko executes diabetes-centric analytics and supplies standardized reports, risk flags and insights to health systems and payers via APIs and web-based tools.

About OneCare(R):

OneCare empowers patients with tools and information needed to live healthier, happier lives, take control of their health information, and connect with their entire care team. OneCare's platform combines a private social network, medical device connectivity, a learning management platform, data analytics, payer and provider connectivity, and reward incentives that bring real time information to the patient leading to a better lifestyle.

CONTACT:

Gary Austin, CEO
Email: gary.austin@onecare.me
Phone: 404-405-7665
Web: www.onecare.me

SOURCE: OneCare